Suzanne Walker
University of Pennsylvania
11 Papers
67 Citations
Suzanne Walker is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 4, co-authored 7 publications.
Chat about Author
Papers
Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer
James P. Stevenson,Corey J. Langer,Robert A. Somer,Tracey L. Evans,Kumar Rajagopalan,Kimberly Krieger,Mona Jacobs-Small,Nikolas Dyanick,Barry Milcarek,Susan Coakley,Suzanne Walker,Beth Eaby-Sandy,Alexandre Hageboutros +12 more
TL;DR: The authors performed a phase 2 study of bevacizumab plus pemetrexed and carboplatin followed by maintenance bevacsumab in patients with advanced, nonsquamous nonsmall cell lung cancer.
23
Cutaneous metastases in breast cancer.
Brianna Kalmykow,Suzanne Walker +1 more
TL;DR: Cutaneous metastases occur more often in breast cancer than in other diseases in women and indicate an incurable diagnosis, so treatment focuses on delaying progressive disease, controlling symptoms, and maintaining quality of life.
22
The Lived Experience of Persons With Malignant Pleural Mesothelioma in the United States.
TL;DR: The lived experience of MPM in the United States is explored to identify unmet patient needs and three major themes about the MPM lived experience emerged: uncertainty/worry about the future, value in relationships, and adapting to a new norm.
15
Bortezomib-induced peripheral neuropathy in patients with multiple myeloma.
Anne Berkowitz,Suzanne Walker +1 more
TL;DR: Oncology nurses must be vigilant and recognize BIPN early to prevent patients from experiencing symptoms and complications that may interfere with their quality of life.
12
Real-world outcomes of pembrolizumab in peritoneal mesothelioma.
Melina E. Marmarelis,Xiao Wang,Leonid Roshkovan,Suzanne Walker,Sally McNulty,Christine Ciunci,John Muira,Sharyn I. Katz,Keith A. Cengel,Giorgos C. Karakousis,Corey J. Langer +10 more
TL;DR: This small number of patients treated with pembrolizumab in malignant mesothelioma clinical trials have included small numbers of peritoneal MM patients, but the efficacy of P in the MPM sub...
5